nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ABCB1—Progesterone—uterine cancer	0.23	0.393	CbGbCtD
Neostigmine—ABCB1—Dactinomycin—uterine cancer	0.182	0.311	CbGbCtD
Neostigmine—ABCB1—Etoposide—uterine cancer	0.103	0.176	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—uterine cancer	0.0701	0.12	CbGbCtD
Neostigmine—Slurred speech—Progesterone—uterine cancer	0.015	0.0362	CcSEcCtD
Neostigmine—Paralysis—Medroxyprogesterone Acetate—uterine cancer	0.00877	0.0211	CcSEcCtD
Neostigmine—Dysarthria—Progesterone—uterine cancer	0.00711	0.0171	CcSEcCtD
Neostigmine—Dysarthria—Medroxyprogesterone Acetate—uterine cancer	0.00644	0.0155	CcSEcCtD
Neostigmine—Osteoarthritis—Progesterone—uterine cancer	0.00488	0.0118	CcSEcCtD
Neostigmine—Osteoarthritis—Medroxyprogesterone Acetate—uterine cancer	0.00442	0.0106	CcSEcCtD
Neostigmine—Cramp muscle—Progesterone—uterine cancer	0.0044	0.0106	CcSEcCtD
Neostigmine—Sweating increased—Progesterone—uterine cancer	0.00411	0.00989	CcSEcCtD
Neostigmine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00398	0.00959	CcSEcCtD
Neostigmine—Cardiovascular disorder—Etoposide—uterine cancer	0.00392	0.00942	CcSEcCtD
Neostigmine—Pollakiuria—Progesterone—uterine cancer	0.0039	0.00938	CcSEcCtD
Neostigmine—Chest discomfort—Etoposide—uterine cancer	0.00389	0.00936	CcSEcCtD
Neostigmine—Drowsiness—Progesterone—uterine cancer	0.00376	0.00906	CcSEcCtD
Neostigmine—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.00376	0.00905	CcSEcCtD
Neostigmine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00896	CcSEcCtD
Neostigmine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00353	0.0085	CcSEcCtD
Neostigmine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00821	CcSEcCtD
Neostigmine—Urinary tract disorder—Progesterone—uterine cancer	0.00334	0.00803	CcSEcCtD
Neostigmine—Connective tissue disorder—Progesterone—uterine cancer	0.00332	0.00799	CcSEcCtD
Neostigmine—Urethral disorder—Progesterone—uterine cancer	0.00331	0.00797	CcSEcCtD
Neostigmine—Lacrimation—Epirubicin—uterine cancer	0.00328	0.00789	CcSEcCtD
Neostigmine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00312	0.0075	CcSEcCtD
Neostigmine—Mediastinal disorder—Progesterone—uterine cancer	0.00304	0.00733	CcSEcCtD
Neostigmine—Lacrimation—Doxorubicin—uterine cancer	0.00303	0.0073	CcSEcCtD
Neostigmine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.00727	CcSEcCtD
Neostigmine—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.00724	CcSEcCtD
Neostigmine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.003	0.00722	CcSEcCtD
Neostigmine—Mental disorder—Progesterone—uterine cancer	0.00296	0.00712	CcSEcCtD
Neostigmine—Flatulence—Progesterone—uterine cancer	0.0029	0.00697	CcSEcCtD
Neostigmine—Muscle spasms—Progesterone—uterine cancer	0.00283	0.0068	CcSEcCtD
Neostigmine—Paralysis—Epirubicin—uterine cancer	0.00278	0.00668	CcSEcCtD
Neostigmine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00664	CcSEcCtD
Neostigmine—Nystagmus—Epirubicin—uterine cancer	0.0027	0.0065	CcSEcCtD
Neostigmine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00645	CcSEcCtD
Neostigmine—Syncope—Progesterone—uterine cancer	0.00264	0.00635	CcSEcCtD
Neostigmine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00263	0.00632	CcSEcCtD
Neostigmine—Loss of consciousness—Progesterone—uterine cancer	0.00258	0.00622	CcSEcCtD
Neostigmine—Paralysis—Doxorubicin—uterine cancer	0.00257	0.00618	CcSEcCtD
Neostigmine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00256	0.00616	CcSEcCtD
Neostigmine—Convulsion—Progesterone—uterine cancer	0.00255	0.00613	CcSEcCtD
Neostigmine—Arthralgia—Progesterone—uterine cancer	0.0025	0.00602	CcSEcCtD
Neostigmine—Nystagmus—Doxorubicin—uterine cancer	0.0025	0.00601	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00249	0.00598	CcSEcCtD
Neostigmine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.00589	CcSEcCtD
Neostigmine—Dry mouth—Progesterone—uterine cancer	0.00245	0.00589	CcSEcCtD
Neostigmine—Anaphylactic shock—Progesterone—uterine cancer	0.0024	0.00578	CcSEcCtD
Neostigmine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00575	CcSEcCtD
Neostigmine—Cardiac arrest—Etoposide—uterine cancer	0.00237	0.00572	CcSEcCtD
Neostigmine—Shock—Progesterone—uterine cancer	0.00236	0.00568	CcSEcCtD
Neostigmine—Nervous system disorder—Progesterone—uterine cancer	0.00235	0.00566	CcSEcCtD
Neostigmine—Tachycardia—Progesterone—uterine cancer	0.00234	0.00564	CcSEcCtD
Neostigmine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00564	CcSEcCtD
Neostigmine—Skin disorder—Progesterone—uterine cancer	0.00233	0.00561	CcSEcCtD
Neostigmine—Hyperhidrosis—Progesterone—uterine cancer	0.00232	0.00558	CcSEcCtD
Neostigmine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00556	CcSEcCtD
Neostigmine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.00546	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00225	0.00542	CcSEcCtD
Neostigmine—Cramp muscle—Etoposide—uterine cancer	0.00225	0.00541	CcSEcCtD
Neostigmine—Hypotension—Progesterone—uterine cancer	0.00224	0.0054	CcSEcCtD
Neostigmine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00534	CcSEcCtD
Neostigmine—Flushing—Dactinomycin—uterine cancer	0.00222	0.00533	CcSEcCtD
Neostigmine—Cardiovascular disorder—Epirubicin—uterine cancer	0.00219	0.00528	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00219	0.00526	CcSEcCtD
Neostigmine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00523	CcSEcCtD
Neostigmine—Insomnia—Progesterone—uterine cancer	0.00217	0.00522	CcSEcCtD
Neostigmine—Dyspnoea—Progesterone—uterine cancer	0.00214	0.00515	CcSEcCtD
Neostigmine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00214	0.00515	CcSEcCtD
Neostigmine—Somnolence—Progesterone—uterine cancer	0.00213	0.00513	CcSEcCtD
Neostigmine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00513	CcSEcCtD
Neostigmine—Bronchospasm—Etoposide—uterine cancer	0.00212	0.00511	CcSEcCtD
Neostigmine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00511	CcSEcCtD
Neostigmine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00508	CcSEcCtD
Neostigmine—Sweating increased—Etoposide—uterine cancer	0.0021	0.00506	CcSEcCtD
Neostigmine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0021	0.00506	CcSEcCtD
Neostigmine—Lacrimation increased—Epirubicin—uterine cancer	0.00209	0.00504	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00207	0.00499	CcSEcCtD
Neostigmine—Dysarthria—Epirubicin—uterine cancer	0.00204	0.00491	CcSEcCtD
Neostigmine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00489	CcSEcCtD
Neostigmine—Cardiovascular disorder—Doxorubicin—uterine cancer	0.00203	0.00489	CcSEcCtD
Neostigmine—Atrioventricular block—Epirubicin—uterine cancer	0.00199	0.00479	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00477	CcSEcCtD
Neostigmine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00473	CcSEcCtD
Neostigmine—Gastrointestinal pain—Progesterone—uterine cancer	0.00196	0.00472	CcSEcCtD
Neostigmine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00467	CcSEcCtD
Neostigmine—Lacrimation increased—Doxorubicin—uterine cancer	0.00194	0.00466	CcSEcCtD
Neostigmine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00465	CcSEcCtD
Neostigmine—Urticaria—Progesterone—uterine cancer	0.00191	0.00459	CcSEcCtD
Neostigmine—Abdominal pain—Progesterone—uterine cancer	0.0019	0.00457	CcSEcCtD
Neostigmine—Dysarthria—Doxorubicin—uterine cancer	0.00189	0.00454	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00452	CcSEcCtD
Neostigmine—Salivary hypersecretion—Epirubicin—uterine cancer	0.00187	0.00451	CcSEcCtD
Neostigmine—Atrioventricular block—Doxorubicin—uterine cancer	0.00184	0.00443	CcSEcCtD
Neostigmine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00428	CcSEcCtD
Neostigmine—Hypersensitivity—Progesterone—uterine cancer	0.00177	0.00425	CcSEcCtD
Neostigmine—Coma—Epirubicin—uterine cancer	0.00176	0.00424	CcSEcCtD
Neostigmine—Salivary hypersecretion—Doxorubicin—uterine cancer	0.00173	0.00417	CcSEcCtD
Neostigmine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00416	CcSEcCtD
Neostigmine—Asthenia—Progesterone—uterine cancer	0.00172	0.00414	CcSEcCtD
Neostigmine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00414	CcSEcCtD
Neostigmine—Urinary tract disorder—Etoposide—uterine cancer	0.00171	0.00411	CcSEcCtD
Neostigmine—Pruritus—Progesterone—uterine cancer	0.0017	0.00409	CcSEcCtD
Neostigmine—Urethral disorder—Etoposide—uterine cancer	0.00169	0.00408	CcSEcCtD
Neostigmine—Diarrhoea—Progesterone—uterine cancer	0.00164	0.00395	CcSEcCtD
Neostigmine—Coma—Doxorubicin—uterine cancer	0.00163	0.00392	CcSEcCtD
Neostigmine—Flushing—Etoposide—uterine cancer	0.0016	0.00386	CcSEcCtD
Neostigmine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00386	CcSEcCtD
Neostigmine—Dizziness—Progesterone—uterine cancer	0.00159	0.00382	CcSEcCtD
Neostigmine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00375	CcSEcCtD
Neostigmine—Mediastinal disorder—Etoposide—uterine cancer	0.00156	0.00375	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00155	0.00372	CcSEcCtD
Neostigmine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.0037	CcSEcCtD
Neostigmine—Vomiting—Progesterone—uterine cancer	0.00153	0.00367	CcSEcCtD
Neostigmine—Rash—Progesterone—uterine cancer	0.00151	0.00364	CcSEcCtD
Neostigmine—Dermatitis—Progesterone—uterine cancer	0.00151	0.00364	CcSEcCtD
Neostigmine—Headache—Progesterone—uterine cancer	0.0015	0.00362	CcSEcCtD
Neostigmine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00358	CcSEcCtD
Neostigmine—Muscle spasms—Etoposide—uterine cancer	0.00145	0.00348	CcSEcCtD
Neostigmine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00346	CcSEcCtD
Neostigmine—Nausea—Progesterone—uterine cancer	0.00143	0.00343	CcSEcCtD
Neostigmine—Osteoarthritis—Epirubicin—uterine cancer	0.0014	0.00337	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00139	0.00334	CcSEcCtD
Neostigmine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00333	CcSEcCtD
Neostigmine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0033	CcSEcCtD
Neostigmine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0033	CcSEcCtD
Neostigmine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00328	CcSEcCtD
Neostigmine—Abdominal pain—Dactinomycin—uterine cancer	0.00134	0.00323	CcSEcCtD
Neostigmine—Cardiac arrest—Epirubicin—uterine cancer	0.00133	0.0032	CcSEcCtD
Neostigmine—Loss of consciousness—Etoposide—uterine cancer	0.00132	0.00318	CcSEcCtD
Neostigmine—Convulsion—Etoposide—uterine cancer	0.0013	0.00314	CcSEcCtD
Neostigmine—Osteoarthritis—Doxorubicin—uterine cancer	0.0013	0.00312	CcSEcCtD
Neostigmine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00311	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00127	0.00306	CcSEcCtD
Neostigmine—Hypersensitivity—Dactinomycin—uterine cancer	0.00125	0.00301	CcSEcCtD
Neostigmine—Cardiac arrest—Doxorubicin—uterine cancer	0.00123	0.00296	CcSEcCtD
Neostigmine—Anaphylactic shock—Etoposide—uterine cancer	0.00123	0.00295	CcSEcCtD
Neostigmine—Asthenia—Dactinomycin—uterine cancer	0.00122	0.00293	CcSEcCtD
Neostigmine—Tachycardia—Etoposide—uterine cancer	0.0012	0.00288	CcSEcCtD
Neostigmine—Skin disorder—Etoposide—uterine cancer	0.00119	0.00287	CcSEcCtD
Neostigmine—Hyperhidrosis—Etoposide—uterine cancer	0.00119	0.00286	CcSEcCtD
Neostigmine—Diarrhoea—Dactinomycin—uterine cancer	0.00116	0.00279	CcSEcCtD
Neostigmine—Hypotension—Etoposide—uterine cancer	0.00115	0.00276	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—uterine cancer	0.00112	0.00269	CcSEcCtD
Neostigmine—Dyspnoea—Etoposide—uterine cancer	0.00109	0.00263	CcSEcCtD
Neostigmine—Somnolence—Etoposide—uterine cancer	0.00109	0.00263	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—uterine cancer	0.00108	0.0026	CcSEcCtD
Neostigmine—Vomiting—Dactinomycin—uterine cancer	0.00108	0.0026	CcSEcCtD
Neostigmine—Rash—Dactinomycin—uterine cancer	0.00107	0.00257	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00106	0.00255	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—uterine cancer	0.00103	0.00249	CcSEcCtD
Neostigmine—Nausea—Dactinomycin—uterine cancer	0.00101	0.00242	CcSEcCtD
Neostigmine—Gastrointestinal pain—Etoposide—uterine cancer	0.001	0.00242	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—uterine cancer	0.000998	0.0024	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—uterine cancer	0.000986	0.00237	CcSEcCtD
Neostigmine—Urticaria—Etoposide—uterine cancer	0.000975	0.00235	CcSEcCtD
Neostigmine—Abdominal pain—Etoposide—uterine cancer	0.00097	0.00234	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—uterine cancer	0.000956	0.0023	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—uterine cancer	0.000952	0.00229	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—uterine cancer	0.000949	0.00228	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—uterine cancer	0.000912	0.0022	CcSEcCtD
Neostigmine—Hypersensitivity—Etoposide—uterine cancer	0.000904	0.00218	CcSEcCtD
Neostigmine—Flushing—Epirubicin—uterine cancer	0.000899	0.00216	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000885	0.00213	CcSEcCtD
Neostigmine—Asthenia—Etoposide—uterine cancer	0.000881	0.00212	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000881	0.00212	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—uterine cancer	0.000878	0.00211	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—uterine cancer	0.000873	0.0021	CcSEcCtD
Neostigmine—Pruritus—Etoposide—uterine cancer	0.000868	0.00209	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—uterine cancer	0.000865	0.00208	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—uterine cancer	0.000848	0.00204	CcSEcCtD
Neostigmine—Diarrhoea—Etoposide—uterine cancer	0.00084	0.00202	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—uterine cancer	0.000832	0.002	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—uterine cancer	0.000831	0.002	CcSEcCtD
Neostigmine—Dizziness—Etoposide—uterine cancer	0.000812	0.00195	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—uterine cancer	0.000811	0.00195	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000808	0.00194	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—uterine cancer	0.0008	0.00193	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—uterine cancer	0.000785	0.00189	CcSEcCtD
Neostigmine—Vomiting—Etoposide—uterine cancer	0.00078	0.00188	CcSEcCtD
Neostigmine—Agitation—Epirubicin—uterine cancer	0.000775	0.00186	CcSEcCtD
Neostigmine—Rash—Etoposide—uterine cancer	0.000774	0.00186	CcSEcCtD
Neostigmine—Dermatitis—Etoposide—uterine cancer	0.000773	0.00186	CcSEcCtD
Neostigmine—Headache—Etoposide—uterine cancer	0.000769	0.00185	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—uterine cancer	0.000769	0.00185	CcSEcCtD
Neostigmine—Syncope—Epirubicin—uterine cancer	0.000756	0.00182	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—uterine cancer	0.00075	0.00181	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—uterine cancer	0.000741	0.00178	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—uterine cancer	0.00073	0.00176	CcSEcCtD
Neostigmine—Nausea—Etoposide—uterine cancer	0.000729	0.00175	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—uterine cancer	0.000718	0.00173	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—uterine cancer	0.000717	0.00173	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000713	0.00172	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—uterine cancer	0.000702	0.00169	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—uterine cancer	0.0007	0.00168	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—uterine cancer	0.000688	0.00166	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—uterine cancer	0.000686	0.00165	CcSEcCtD
Neostigmine—Shock—Epirubicin—uterine cancer	0.000677	0.00163	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—uterine cancer	0.000676	0.00163	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—uterine cancer	0.000675	0.00162	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—uterine cancer	0.000672	0.00162	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—uterine cancer	0.000668	0.00161	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—uterine cancer	0.000665	0.0016	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—uterine cancer	0.000664	0.0016	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00066	0.00159	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—uterine cancer	0.000649	0.00156	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—uterine cancer	0.000643	0.00155	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000637	0.00153	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000627	0.00151	CcSEcCtD
Neostigmine—Shock—Doxorubicin—uterine cancer	0.000626	0.00151	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—uterine cancer	0.000624	0.0015	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—uterine cancer	0.000622	0.0015	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—uterine cancer	0.000621	0.0015	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—uterine cancer	0.000618	0.00149	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000615	0.00148	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—uterine cancer	0.000613	0.00148	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—uterine cancer	0.000612	0.00147	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—uterine cancer	0.000595	0.00143	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000594	0.00143	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00058	0.0014	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—uterine cancer	0.000576	0.00139	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—uterine cancer	0.000568	0.00137	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—uterine cancer	0.000566	0.00136	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000563	0.00135	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00055	0.00132	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—uterine cancer	0.000547	0.00132	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—uterine cancer	0.000544	0.00131	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000521	0.00125	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—uterine cancer	0.000507	0.00122	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—uterine cancer	0.000506	0.00122	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—uterine cancer	0.000503	0.00121	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—uterine cancer	0.000494	0.00119	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—uterine cancer	0.000487	0.00117	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—uterine cancer	0.000471	0.00113	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—uterine cancer	0.000469	0.00113	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—uterine cancer	0.000457	0.0011	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—uterine cancer	0.000455	0.0011	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—uterine cancer	0.00045	0.00108	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—uterine cancer	0.000437	0.00105	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—uterine cancer	0.000436	0.00105	CcSEcCtD
Neostigmine—Rash—Epirubicin—uterine cancer	0.000434	0.00104	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—uterine cancer	0.000433	0.00104	CcSEcCtD
Neostigmine—Headache—Epirubicin—uterine cancer	0.000431	0.00104	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—uterine cancer	0.000421	0.00101	CcSEcCtD
Neostigmine—Nausea—Epirubicin—uterine cancer	0.000409	0.000984	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—uterine cancer	0.000405	0.000974	CcSEcCtD
Neostigmine—Rash—Doxorubicin—uterine cancer	0.000401	0.000966	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—uterine cancer	0.000401	0.000965	CcSEcCtD
Neostigmine—Headache—Doxorubicin—uterine cancer	0.000399	0.00096	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—uterine cancer	0.000378	0.00091	CcSEcCtD
